1. Home
  2. NKTX vs VSTA Comparison

NKTX vs VSTA Comparison

Compare NKTX & VSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTX
  • VSTA
  • Stock Information
  • Founded
  • NKTX 2015
  • VSTA 1966
  • Country
  • NKTX United States
  • VSTA Brazil
  • Employees
  • NKTX N/A
  • VSTA N/A
  • Industry
  • NKTX Biotechnology: Pharmaceutical Preparations
  • VSTA Other Consumer Services
  • Sector
  • NKTX Health Care
  • VSTA Real Estate
  • Exchange
  • NKTX Nasdaq
  • VSTA Nasdaq
  • Market Cap
  • NKTX 225.1M
  • VSTA 215.4M
  • IPO Year
  • NKTX 2020
  • VSTA 2020
  • Fundamental
  • Price
  • NKTX $3.19
  • VSTA $2.40
  • Analyst Decision
  • NKTX Strong Buy
  • VSTA Sell
  • Analyst Count
  • NKTX 5
  • VSTA 2
  • Target Price
  • NKTX $18.20
  • VSTA $3.00
  • AVG Volume (30 Days)
  • NKTX 760.2K
  • VSTA 6.6K
  • Earning Date
  • NKTX 11-11-2024
  • VSTA 11-07-2024
  • Dividend Yield
  • NKTX N/A
  • VSTA N/A
  • EPS Growth
  • NKTX N/A
  • VSTA N/A
  • EPS
  • NKTX N/A
  • VSTA N/A
  • Revenue
  • NKTX N/A
  • VSTA $282,280,783.00
  • Revenue This Year
  • NKTX N/A
  • VSTA $13.10
  • Revenue Next Year
  • NKTX N/A
  • VSTA $11.42
  • P/E Ratio
  • NKTX N/A
  • VSTA N/A
  • Revenue Growth
  • NKTX N/A
  • VSTA 14.56
  • 52 Week Low
  • NKTX $1.90
  • VSTA $2.11
  • 52 Week High
  • NKTX $16.24
  • VSTA $4.55
  • Technical
  • Relative Strength Index (RSI)
  • NKTX 33.30
  • VSTA 47.57
  • Support Level
  • NKTX $3.08
  • VSTA $2.53
  • Resistance Level
  • NKTX $3.52
  • VSTA $2.79
  • Average True Range (ATR)
  • NKTX 0.27
  • VSTA 0.16
  • MACD
  • NKTX 0.01
  • VSTA 0.00
  • Stochastic Oscillator
  • NKTX 15.23
  • VSTA 54.88

About NKTX Nkarta Inc.

Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.

About VSTA Vasta Platform Limited

Vasta Platform Ltd operates as an education company in Brazil, engaged in providing end-to-end educational and digital solutions that cater to all needs of private schools operating in the K-12 educational segment. Its business segments are Content and EdTech Platform, and Digital Platform. The Content and EdTech platform derives its results from educational content solutions through digital and printed content, including textbooks, learning systems and other complementary educational services. The Digital Platform enables private schools to aggregate multiple learning strategies and helps them to focus on education through the Business' physical and digital e-commerce platform and other digital services.

Share on Social Networks: